CTRI/2018/06/014412
Completed
Phase 2
ASSESSMENT AND OCCURENCE OF ADVERSE EFFECTS AFTER CONSUMPTION OF SIDDHA DRUGS
Ayothidoss pandithar hospital0 sites100 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- patients reporting with adverse effects after consumption of siddha drugs
- Sponsor
- Ayothidoss pandithar hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients reporting with adverse effect after taking siddha medicines in NIS OPD
Exclusion Criteria
- •allopathy or any other alternative medicine taken from outside
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment on no observed adverse effect level of the test food (HBF2019-01) for loose stoolsHealthy adultJPRN-UMIN000037115Hayashibara Co., Ltd.20
Recruiting
Not Applicable
Prospective evaluation of adverse events during neonatal endotracheal intubationsRespiratory insufficiency in preterm and term babiesDRKS00013575Zentrum für Kinder- und Jugendmedizin Universitätsmedizin Mainz, Abteilung Neonatologie93
Completed
Phase 2
Evaluation of the occurrence, effect and side effects oFcyclophosfamid and rituximab in the tratment of children with NEPHROTIC SYNDROM resistance to STEROID that referred to Hazrate Massumeh hospital .IRCT20170527034146N2Ghoum University of Medical Sciences102
Completed
Not Applicable
Assessment of the incidence and nature of adverse events and their association with human error in neurosurgery. A prospective observation.Any diseases pertaining to the neurosurgical specialty.DRKS00024548Klinikum rechts der Isar der TU München4,176
Not yet recruiting
Not Applicable
A descriptive study of AEFI among pediatric age group vaccinated at SPINH attached SMS hospital JaipurCTRI/2024/05/067330il